Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research -CNS and Neurological Disorders

Volume 2

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-1-60805-776-4 (Print)
ISBN: 978-1-60805-775-7 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080577571130201

Introduction

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The second volume of this series features eight chapters that cover a variety of topics including:

-Treatment of multiple sclerosis and schizophrenia

-Neurochemistry of tremors

-Relationship between GABA and Alzheimer’s disease therapy

-Relationship between neurological diseases and cancer

-Research on angiogenesis-related blindness

Contributors

Editor(s):
Atta-ur-Rahman FRS
Honorary Life Fellow, Kings College
University of Cambridge
UK




Contributor(s):
Alessandro Ricci
Operative Unit of Neurosurgery
San Salvatore HospitalL’Aquila
L’Aquila
Italy


Alfonso M. Marrelli
Operative Unit of Neurosurgery
San Salvatore HospitalL’Aquila
L’Aquila
Italy


Brian A. Wall
Susan Lehman Cullman Laboratory for Cancer Research
Ernest Mario School of Pharmacy
Rutgers, the State University of New Jersey
Piscataway
NJ, 08854
USA


Christian Bouwkamp
Department of Neurobiological Psychiatry
Erasmus MC Rotterdam
The Netherlands


Donatella Trovarelli
Operative Unit of Neurosurgery
San Salvatore HospitalL’Aquila
L’Aquila
Italy


Dong Hyun Jo
Fight Against Angiogenesis-Related Blindness (FARB) Laboratory
and Department of Ophthalmology
College of Medicine
Seoul National University
Seoul, 110-744
Republic of Korea


Elena García-Martín
Department of Biochemistry and Molecular Biology
University of Extremadura
Cáceres, Spain and AMGenomics
Edificio Tajo, Avda. de la Universidad s/n
Cáceres
Spain


Félix Javier Jiménez-Jiménez
Section of Neurology
Hospital Universitario del Sureste
Arganda del Rey
Madrid
Spain


Hortensia Alonso-Navarro
Section of Neurology
Hospital Universitario del Sureste
Arganda del Rey
Madrid
Spain


Jaime Almeida
Department of Neurobiological Psychiatry
Erasmus MC Rotterdam
The Netherlands


Javier Yajeya
Department of Physiology and Pharmacology
University of Salamanca
Salamanca
Spain


Jeong Hun Kim
Fight Against Angiogenesis-Related Blindness (FARB) Laboratory
Department of Ophthalmology, College of Medicine
Seoul National University
Seoul, 110-744
Republic of Korea


Jin Hyoung Kim
Fight Against Angiogenesis-Related Blindness (FARB) Laboratory and Department of Ophthalmology
College of Medicine, Seoul National University
Seoul, 110-744
Republic of Korea


José A.G. Agúndez
AMGenomics, Edificio Tajo, Avda. de la Universidad s/n and Department of Pharmacology
University of Extremadura
Cáceres
Spain


Juan D. Navarro-López
Neurophysiology and Behavior Lab
School of Medicine of Ciudad Real
University of Castilla-La Mancha
Ciudad Real
Spain


Letteria Spadaro
IRCCS Centro Neurolesi “Bonino-Pulejo
Messina
Spain


Lydia Jiménez-Diaz
Neurophysiology and Behavior Lab
School of Medicine of Ciudad Real
University of Castilla-La Mancha
Ciudad Real
Spain


Maria G. Cifone
Department of Health
Life and Environmental Sciences
University of L’Aquila
L’Aquila
Italy


Mauricio O. Nava-Mesa
Neurophysiology and Behavior Lab
School of Medicine of Ciudad Real
University of Castilla-La Mancha
Ciudad Real
Spain


Mickael Bonnan
Service de Neurologie
Hôpital F. Mitterrand
Pau
France


Philippe Cabre


Placido Bramanti
IRCCS Centro Neurolesi “Bonino-Pulejo”
Messina
Italy


Renato Galzio
Department of Health, Life and Environmental Sciences
University of L’Aquila
and Operative Unit of Neurosurgery
San Salvatore Hospital
L’Aquila
Italy


Rosella Ciurleo
IRCCS Centro Neurolesi “Bonino-Pulejo”
Messina
Italy


Sabino Luzzi
Operative Unit of Neurosurgery
San Salvatore Hospital
L’Aquila
Italy


Seung-Shick Shin
The Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick
NJ, 08903
USA


Silvia Marino
IRCCS Centro Neurolesi “Bonino-Pulejo”
Messina
Italy


Soheila Raysi Dehcordi
Department of Health, Life and Environmental Sciences
University of L’Aquila
L’Aquila
Italy


Suzie Chen
The Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick
NJ, 08903
USA
/
Susan Lehman Cullman Laboratory for Cancer Research
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway
NJ, 08854
USA




RELATED BOOKS

.Frontiers in Clinical Drug Research-Dementia.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Cellular Mechanisms in Alzheimer’s Disease.